Supplementary Materials

The PDF file includes:

  • Fig. S1. TCR profile and functional characteristics of individual patient products.
  • Fig. S2. In vivo fate of infused mTAA T cell products.
  • Fig. S3. TAA-directed killing of antigen-positive MM cells.
  • Table S1. Disease responses and outcomes for individual patients (group A).
  • Table S2. Disease responses and outcomes for individual patients (group B).
  • Table S3. After relapse of progression treatments and response.

[Download PDF]

Other Supplementary Material for this manuscript includes the following:

  • Data file S1 (Microsoft Excel format). List of genes differentially expressed in patient #3.
  • Data file S2 (Microsoft Excel format). All genes and FPKM values (raw data) for mRNA sequencing performed on patient #3.
  • Data file S3 (Microsoft Excel format). Latest version of approved clinical protocol.
  • Data file S4 (.pdf format). Primary data.